On Wednesday, Shares of Geron Corporation (NASDAQ:GERN), gained 3.42% to $3.02.
Geron Corporation, declared that John A. Scarlett, M.D., President and Chief Executive Officer, is planned to present at the BIO Investor Forum in San Francisco at 8:30 a.m. Pacific Time on Wednesday, October 21.
Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies.
Shares of Fortune Brands Home & Security Inc (NYSE:FBHS), declined -2.46% to $47.64, during its last trading session.
A new season brings new safety precautions to consider as daylight quickly turns to dusk and temperatures start to drop. With school routines and activity plans in full swing, Master Lock is reminding families to fall back into safety without falling victim to vulnerabilities with assistful advice and reliable products.
“As families settle into the new school year, we want to remind them of security precautions to assist ensure they have a safe season,” said Rebecca Smith, vice president, marketing for Master Lock. “Although plans are busy, it’s important for families to remember to keep safety and security a precedingity and to address safety topics.”
Fortune Brands Home & Security, Inc. provides home and security products for use in residential home repair, remodeling, new construction, security applications, and storage. It operates in four segments: Cabinets, Plumbing, Doors, and Security.
Finally, Amedica Corporation (NASDAQ:AMDA), ended its last trade with -4.75% loss, and closed at $0.281.
Amedica Corporation, declared the release of its Scorpion articulating inserter to accompany the Valeo II™ TL interbody fusion device system. The Scorpion inserter will be commercially available mid-November 2015, and will aide in minimally-invasive transforaminal lumbar interbody fusion surgeries.
“The TLIF approach can be particularly complex, requiring superior surgeon expertise and precision,” said Dr. Sonny Bal, chairman and CEO of Amedica Corporation. “This articulating inserter, used with our Valeo II TL and Valeo II TL Round systems, offers greater control and placement accuracy for our silicon nitride interbody fusion device while performing this minimally-invasive technique. The release of Scorpion demonstrates our determination to enhance patient care through our proprietary material and innovative surgical solutions.”
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
